Perioperative antiplatelet therapy in patients at risk for coronary stent thrombosis undergoing noncardiac surgery

Discontinuation of antiplatelet therapy

Discontinuation of antiplatelet therapy prior to low-risk noncardiac surgery in patients with drug-eluting stents: A retrospective cohort study

✍ Daniel J. Brotman; Mihir Bakhru; Wael Saber; Ashish Aneja; Deepak L. Bhatt; Kath 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

## Abstract ## BACKGROUND Drug‐eluting coronary stents (DESs) pose a challenge in the perioperative period. Sirolimus and paclitaxel may inhibit reendothelialization of the traumatized vessel, making it vulnerable to platelet‐mediated thrombosis. Given the anecdotal evidence and case series sugges